drugset / Trial / NCT00002172

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

NCT00002172

Open-labelTreatment

Summary

To provide product through an expanded access program to HIV-infected patients with CD4 counts less than 300 cells/ml.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Remune Vaccine